Recall of EpiPen

This month, the U.S. Food and Drug Administration alerted consumers to Meridian Medical Technologies’ voluntary recall of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products, which are commonly used for emergency treatment of serious allergic reactions. The main reason for the recall is because of the possibility that these devices may contain a defective part, which may result in failure to activate.

Although the number of reported failures are minuscule, EpiPen produces which potentially contain a defective function are being recalled due to the possibility of life-threatening risk in the event of a severe allergic reaction. The 13 lots identified were distributed between December 17, 2015, and July 1, 2016, and only affect the United States.

The following is a list of the U.S. impacted lots:

The FDA requests any consumers and healthcare providers to report any adverse reactions or device malfunctions to the FDA’s MedWatch program by either:

• Completing and submitting the report online at www.fda.gov/medwatch/report.htm
• Downloading and completing the form, then submitting it via fax at 800-FDA-0178.

If you suffered an injury caused by a defective medical product in Weston, contact Rash Mueller. today.